ZA200205162B - Linezolid-crystal Form II. - Google Patents

Linezolid-crystal Form II. Download PDF

Info

Publication number
ZA200205162B
ZA200205162B ZA200205162A ZA200205162A ZA200205162B ZA 200205162 B ZA200205162 B ZA 200205162B ZA 200205162 A ZA200205162 A ZA 200205162A ZA 200205162 A ZA200205162 A ZA 200205162A ZA 200205162 B ZA200205162 B ZA 200205162B
Authority
ZA
South Africa
Prior art keywords
process according
solvent
phenyl
fluoro
morpholinyl
Prior art date
Application number
ZA200205162A
Other languages
English (en)
Inventor
Michael S Bergren
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22658183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200205162(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of ZA200205162B publication Critical patent/ZA200205162B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200205162A 2000-02-02 2002-06-27 Linezolid-crystal Form II. ZA200205162B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17983700P 2000-02-02 2000-02-02

Publications (1)

Publication Number Publication Date
ZA200205162B true ZA200205162B (en) 2003-09-29

Family

ID=22658183

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200205162A ZA200205162B (en) 2000-02-02 2002-06-27 Linezolid-crystal Form II.

Country Status (30)

Country Link
EP (1) EP1255754B1 (da)
JP (1) JP5235256B2 (da)
KR (3) KR100781815B1 (da)
CN (1) CN1221547C (da)
AR (1) AR027261A1 (da)
AT (1) ATE297920T1 (da)
AU (1) AU782138B2 (da)
BR (1) BR0107667A (da)
CA (1) CA2395603C (da)
CO (1) CO5261555A1 (da)
CZ (1) CZ302292B6 (da)
DE (1) DE60111497T2 (da)
DK (1) DK1255754T3 (da)
EA (1) EA004434B1 (da)
EE (1) EE05197B1 (da)
ES (1) ES2242728T3 (da)
HU (1) HUP0301076A3 (da)
IL (1) IL151010A0 (da)
MX (1) MXPA02007471A (da)
MY (1) MY122829A (da)
NO (2) NO323459B1 (da)
NZ (1) NZ520541A (da)
PE (1) PE20011086A1 (da)
PL (1) PL356433A1 (da)
PT (1) PT1255754E (da)
SI (1) SI1255754T1 (da)
SK (1) SK287025B6 (da)
TW (1) TWI297687B (da)
WO (1) WO2001057035A1 (da)
ZA (1) ZA200205162B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100490643B1 (ko) * 2002-10-29 2005-05-19 한국과학기술연구원 새로운 메틸리덴 피페리딘일 옥사졸리딘온 유도체 및이들의 제조방법
ATE442364T1 (de) 2003-10-16 2009-09-15 Symed Labs Ltd Kristalline form von linezolid
PL1737850T3 (pl) 2004-04-19 2008-02-29 Symed Labs Ltd Nowy sposób wytwarzania linezolidu i związków pokrewnych
MX2007000084A (es) * 2004-06-29 2007-06-14 Teva Pharma Formas solidas de linezolid y procesos para la preparacion delas mismas.
US20060142283A1 (en) * 2004-06-29 2006-06-29 Judith Aronhime Crystalline form IV of linezolid
CA2602073A1 (en) * 2005-02-24 2006-08-31 Teva Pharmaceutical Industries Ltd. Processes for the preparation of linezolid intermediate
KR20070062504A (ko) * 2005-06-22 2007-06-15 테바 파마슈티컬 인더스트리즈 리미티드 테가세로드 말레이트의 다형태
US20070020329A1 (en) * 2005-07-20 2007-01-25 Ruth Tenengauzer Methods of formulating linezolid
WO2007102082A1 (en) * 2006-03-09 2007-09-13 Glenmark Pharmaceuticals Limited High oxazolidinone content solid dosage forms
US20080139563A1 (en) * 2006-10-23 2008-06-12 Concert Pharmaceuticals Inc. Oxazolidinone derivatives and methods of use
WO2011050826A1 (en) 2009-10-28 2011-05-05 Synthon B.V. Process for making crystalline form a of linezolid
EP2899185B1 (en) 2010-04-30 2018-01-31 Indiana University Research and Technology Corporation Processes for preparing linezolid
EP2690100A1 (en) 2010-08-11 2014-01-29 Synhton B.V. Process for making linezolid
EP2603505A1 (en) 2010-08-11 2013-06-19 Synthon BV Process for making linezolid
EP2593440A1 (en) * 2011-02-24 2013-05-22 Lee Pharma Limited Anhydrous linezolid crystalline form-ii
EP2683696A1 (en) 2011-03-09 2014-01-15 Synthon BV Process for making crystalline form a of linezolid
CN102731341A (zh) * 2011-04-13 2012-10-17 上海医药工业研究院 用于制备利奈唑胺的中间体及其制备方法
CN102766106A (zh) * 2011-05-03 2012-11-07 江苏豪森医药集团有限公司 利奈唑胺的新晶型及其制备方法
CN102399200B (zh) * 2011-12-14 2013-12-04 浙江新东港药业股份有限公司 一种利用悬浮结晶法制备利奈唑胺晶型ⅰ的方法
EP2852580A1 (en) 2012-01-24 2015-04-01 Jubilant Life Sciences Ltd. Improved process for the preparation of stable crystalline form-i of linezolid, substantially free of residual solvent
WO2013120496A1 (en) 2012-02-14 2013-08-22 Pharmathen S.A. Process for the preparation of linezolid in crystalline form and salts thereof
CN102643245A (zh) * 2012-04-10 2012-08-22 杭州华东医药集团生物工程研究所有限公司 一种利奈唑胺晶型及其制备方法
WO2014071990A1 (en) 2012-11-09 2014-05-15 Synthon Bv Process for making linezolid
JP7101694B2 (ja) 2016-11-16 2022-07-15 ペルシカ ファーマシューティカルズ リミテッド 腰痛のための抗生物質製剤
WO2019097242A1 (en) 2017-11-16 2019-05-23 Persica Pharmaceuticals Ltd. Linezolid formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
PT892792E (pt) * 1996-04-11 2002-05-31 Upjohn Co Processo para a preparacao de oxazolidinonas
CA2304100A1 (en) * 1997-11-07 1999-05-20 Pharmacia & Upjohn Company Process to produce oxazolidinones

Also Published As

Publication number Publication date
JP2003522175A (ja) 2003-07-22
EA004434B1 (ru) 2004-04-29
SK287025B6 (sk) 2009-10-07
EA200200819A1 (ru) 2003-02-27
DE60111497T2 (de) 2006-05-18
DE60111497D1 (de) 2005-07-21
KR20080044358A (ko) 2008-05-20
PL356433A1 (en) 2004-06-28
DK1255754T3 (da) 2005-08-22
CZ20022635A3 (cs) 2002-10-16
KR100781815B1 (ko) 2007-12-03
EP1255754A1 (en) 2002-11-13
CN1221547C (zh) 2005-10-05
CA2395603A1 (en) 2001-08-09
WO2001057035A1 (en) 2001-08-09
AU782138B2 (en) 2005-07-07
NO20023654L (no) 2002-08-01
IL151010A0 (en) 2003-02-12
HK1051196A1 (en) 2003-07-25
JP5235256B2 (ja) 2013-07-10
BR0107667A (pt) 2002-10-08
EP1255754B1 (en) 2005-06-15
CA2395603C (en) 2010-03-23
ATE297920T1 (de) 2005-07-15
KR20020072300A (ko) 2002-09-14
KR100864745B1 (ko) 2008-10-22
TWI297687B (en) 2008-06-11
SK9942002A3 (en) 2002-11-06
PT1255754E (pt) 2005-11-30
PE20011086A1 (es) 2001-10-04
NZ520541A (en) 2004-02-27
EE05197B1 (et) 2009-08-17
MY122829A (en) 2006-05-31
AR027261A1 (es) 2003-03-19
MXPA02007471A (es) 2002-12-13
CN1394207A (zh) 2003-01-29
NO20065836L (no) 2002-08-01
CZ302292B6 (cs) 2011-02-09
HUP0301076A2 (hu) 2003-08-28
ES2242728T3 (es) 2005-11-16
KR20070087178A (ko) 2007-08-27
AU3275501A (en) 2001-08-14
EE200200420A (et) 2003-12-15
HUP0301076A3 (en) 2004-06-28
CO5261555A1 (es) 2003-03-31
NO323459B1 (no) 2007-05-14
SI1255754T1 (sl) 2005-12-31
NO20023654D0 (no) 2002-08-01

Similar Documents

Publication Publication Date Title
US6444813B2 (en) Linezolid-crystal form II
CA2395603C (en) Linezolid-crystal form ii
EP1673370B1 (en) Crystalline form of linezolid
EP1699773A2 (en) Processes for preparation of crystalline mycophenolate sodium
WO2011051384A1 (en) Process for making crystalline form a of linezolid
JP2007524569A (ja) ナテグリニドの結晶形
EP2825525A1 (en) New polymorphic form of a long-acting beta-2 adrenoceptor agonist
HK1051196B (en) Linezolid-crystal form ii
WO2022023291A1 (en) Method for the purification of vilanterol trifenatate
EP2493867A1 (en) Process for making crystalline form a of linezolid